QIAGEN announces European launch of therascreen(r) IDH1/2 test for gliomas QIAGEN announces European launch of therascreen® IDH1/2 test for gliomas as well as a IDH1/2-related collaboration with Mayo Clinic QIAGEN's therascreen® IDH1/2 RGQ Kit is the first...